you are currently viewing:Defiance Launches LLYZ: The First 2X Short ETF for Eli LillySeptember 3, 2025--Defiance ETFs, a leader in thematic and leveraged exchange-traded funds, today announced the launch of the Defiance Daily Target 2X Short LLY ETF (Ticker: LLYZ). This fund provides investors with amplified 2X inverse daily exposure to the performance of Eli Lilly and Company (NYSE: LLY), enabling retail investors to seek enhanced downside exposure without the need for a margin account. LLYZ seeks to deliver daily investment results. before fees and expenses, of -200% of the daily performance of Eli Lilly and Company. The Fund utilizes derivatives such as swaps and options to achieve its leveraged objectives, offering precise exposure to this issuer. Source: Defiance ETFs |
August 14, 2025--Milestone Reflects Growing Demand for High-Conviction, Tactical Exposure to the Innovation Economy.
Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, proudly announces that it has surpassed $1 billion in assets under management (AUM) just over one year after its launch in May 2024.
August 12, 2025--After careful consideration, Exchange Traded Concepts, LLC, the Fund's investment adviser has recommended, and the Board of Trustees of Exchange Traded Concepts Trust has approved, the termination and liquidation of the Fund pursuant to the terms of a Plan of Liquidation. Accordingly, the Fund is expected to cease operations and liquidate on or about August 29, 2025 (the "Liquidation Date").
August 12, 2025--Two new 2X long single-stock funds focused on AI-enabling infrastructure names
Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, today announced the launch of two new single-stock leveraged ETFs. Both funds are first-to-market strategies and are listed on Cboe. The funds aim to deliver twice (200%) the daily performance of a specific underlying stock.